Two studies reported circulating irisin levels in patients with SCH [32, 37], and there was no difference in irisin levels between patients with SCH and the control group (MD 4.21, 95% CI -0.13 to 8.55). This evidence concerns the gene FNDC5 and spindle cell hemangioma.